Kuros Biosciences AG (LON:0RHR)
London · Delayed Price · Currency is GBP · Price in CHF 23.62
-0.01 (-0.06%)
At close: Sep 12, 2025
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 848.55 million as of September 18, 2025. Its market cap has increased by 64.19% in one year.
Market Cap
848.55M
Enterprise Value
833.06M
Revenue
94.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.62
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 2.27B to 848.55M, a decrease of -62.55%. That is a compound annual growth rate of -9.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 848.55M | 19.55% |
| Dec 30, 2024 | 709.81M | 493.45% |
| Dec 29, 2023 | 119.61M | 148.06% |
| Dec 30, 2022 | 48.22M | -5.76% |
| Dec 30, 2021 | 51.17M | -7.21% |
| Dec 30, 2020 | 55.14M | 27.49% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 176.72B |
| GSK plc | 59.31B |
| Haleon | 30.58B |
| Smith & Nephew | 11.87B |
| ConvaTec Group | 4.76B |
| Hikma Pharmaceuticals | 3.60B |
| HUTCHMED (China) | 2.18B |
| Genus | 1.66B |